Drugs Made In America Acquisition II Corp. Unit (DMIIU)
Market Open
23 Oct, 01:31 PM
NASDAQ (NMS) NASDAQ (NMS) Primary $
10. 23
0
0%
$
711.48M Market Cap
- Div Yield
4,200 Volume
$ 10.23
Previous Close Want to track DMIIU and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Drugs Made In America Acquisition II Corp. Unit Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| SR Simon Raykher Kepos Capita LLP | 210,000 | $2.11M | $2.15M | $40,510.01 | 1.92% |
| CW CaSaundra Wu Westchester Capital Management LLC | 502,914 | $5.02M | $5.15M | $127,173.13 | 2.53% |
| RS Robert Sterner Rangeley Capital LLC | 55,612 | $557,530.44 | $568,966.37 | $11,435.93 | 2.05% |
| BO Brian Oliveira Clear Street Group Inc. | 8,084 | $80,395.37 | $82,707.4 | $2,312.03 | 2.88% |
2026 © Marketlog. All Rights Reserved.
